Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Noninvasive Ventilation | 14 | 2023 | 37 | 6.370 |
Why?
|
| Respiratory Insufficiency | 15 | 2023 | 183 | 6.240 |
Why?
|
| Respiration, Artificial | 17 | 2024 | 379 | 5.260 |
Why?
|
| Diaphragm | 4 | 2024 | 52 | 1.960 |
Why?
|
| Early Ambulation | 5 | 2023 | 30 | 1.910 |
Why?
|
| Critical Illness | 7 | 2025 | 327 | 1.890 |
Why?
|
| Hypnotics and Sedatives | 4 | 2024 | 136 | 1.730 |
Why?
|
| Physical Therapy Modalities | 4 | 2021 | 88 | 1.510 |
Why?
|
| Intensive Care Units | 11 | 2025 | 429 | 1.370 |
Why?
|
| Critical Care | 8 | 2023 | 397 | 1.040 |
Why?
|
| Head Protective Devices | 5 | 2023 | 23 | 1.020 |
Why?
|
| Masks | 2 | 2016 | 30 | 0.990 |
Why?
|
| Metabolome | 1 | 2025 | 61 | 0.900 |
Why?
|
| Ventilator Weaning | 1 | 2024 | 25 | 0.890 |
Why?
|
| Sepsis | 3 | 2025 | 353 | 0.820 |
Why?
|
| Feces | 1 | 2025 | 349 | 0.810 |
Why?
|
| Respiratory Mechanics | 1 | 2024 | 103 | 0.810 |
Why?
|
| Immunity | 2 | 2022 | 149 | 0.800 |
Why?
|
| Analgesia | 2 | 2020 | 61 | 0.780 |
Why?
|
| Intubation | 2 | 2023 | 22 | 0.750 |
Why?
|
| Oxygen Inhalation Therapy | 4 | 2022 | 63 | 0.740 |
Why?
|
| Humans | 51 | 2025 | 92359 | 0.720 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2025 | 555 | 0.710 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 329 | 0.700 |
Why?
|
| Pneumonia | 1 | 2022 | 187 | 0.690 |
Why?
|
| Intubation, Intratracheal | 3 | 2023 | 152 | 0.680 |
Why?
|
| Betacoronavirus | 2 | 2020 | 270 | 0.660 |
Why?
|
| Body Temperature | 1 | 2020 | 128 | 0.660 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 166 | 0.660 |
Why?
|
| Oxygen | 4 | 2022 | 762 | 0.620 |
Why?
|
| Immunocompromised Host | 2 | 2018 | 145 | 0.590 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 315 | 0.580 |
Why?
|
| Laryngeal Masks | 1 | 2018 | 13 | 0.580 |
Why?
|
| Muscle Weakness | 2 | 2018 | 64 | 0.570 |
Why?
|
| Lidocaine | 1 | 2018 | 67 | 0.560 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 82 | 0.540 |
Why?
|
| Lung Injury | 1 | 2017 | 57 | 0.530 |
Why?
|
| Shock, Septic | 3 | 2023 | 108 | 0.500 |
Why?
|
| Pandemics | 3 | 2021 | 807 | 0.490 |
Why?
|
| Pain | 1 | 2018 | 406 | 0.470 |
Why?
|
| Positive-Pressure Respiration | 5 | 2023 | 46 | 0.460 |
Why?
|
| Immobilization | 1 | 2014 | 21 | 0.450 |
Why?
|
| Hypoxia | 7 | 2023 | 671 | 0.420 |
Why?
|
| Asthma | 2 | 2020 | 1004 | 0.410 |
Why?
|
| Hyperglycemia | 1 | 2014 | 176 | 0.410 |
Why?
|
| Aged | 12 | 2025 | 19949 | 0.380 |
Why?
|
| Conscious Sedation | 2 | 2024 | 72 | 0.370 |
Why?
|
| Computers, Handheld | 1 | 2012 | 34 | 0.370 |
Why?
|
| Male | 18 | 2025 | 43938 | 0.370 |
Why?
|
| Internal Medicine | 2 | 2013 | 366 | 0.360 |
Why?
|
| Perioperative Care | 1 | 2013 | 173 | 0.350 |
Why?
|
| Female | 18 | 2025 | 47911 | 0.350 |
Why?
|
| Middle Aged | 13 | 2025 | 27057 | 0.340 |
Why?
|
| Adult | 13 | 2023 | 27558 | 0.340 |
Why?
|
| Respiration | 2 | 2023 | 269 | 0.330 |
Why?
|
| Fever | 2 | 2020 | 130 | 0.320 |
Why?
|
| Length of Stay | 4 | 2022 | 790 | 0.300 |
Why?
|
| Cytokines | 3 | 2023 | 842 | 0.290 |
Why?
|
| Prospective Studies | 4 | 2025 | 4474 | 0.270 |
Why?
|
| Clinical Competence | 1 | 2012 | 809 | 0.250 |
Why?
|
| Internship and Residency | 2 | 2013 | 1087 | 0.250 |
Why?
|
| Serratia Infections | 1 | 2025 | 6 | 0.230 |
Why?
|
| Enterobactin | 1 | 2025 | 7 | 0.230 |
Why?
|
| Ventilators, Mechanical | 2 | 2022 | 37 | 0.230 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2025 | 24 | 0.230 |
Why?
|
| Metabolomics | 1 | 2025 | 95 | 0.220 |
Why?
|
| Dexmedetomidine | 1 | 2024 | 14 | 0.220 |
Why?
|
| Dysbiosis | 1 | 2025 | 89 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2023 | 8729 | 0.210 |
Why?
|
| Respiratory Rate | 1 | 2023 | 22 | 0.200 |
Why?
|
| Cohort Studies | 4 | 2023 | 2980 | 0.190 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 74 | 0.190 |
Why?
|
| Postoperative Complications | 1 | 2013 | 2454 | 0.190 |
Why?
|
| Atrophy | 1 | 2022 | 127 | 0.190 |
Why?
|
| Respiratory Dead Space | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hospital Mortality | 2 | 2020 | 445 | 0.170 |
Why?
|
| Statistics as Topic | 1 | 2021 | 234 | 0.170 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2020 | 32 | 0.170 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 205 | 0.170 |
Why?
|
| Siblings | 1 | 2020 | 108 | 0.170 |
Why?
|
| Muscular Atrophy | 1 | 2020 | 46 | 0.160 |
Why?
|
| Patients | 1 | 2020 | 107 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 203 | 0.160 |
Why?
|
| Bacteremia | 1 | 2020 | 105 | 0.160 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2019 | 3 | 0.160 |
Why?
|
| Tidal Volume | 1 | 2019 | 55 | 0.150 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 247 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2021 | 800 | 0.150 |
Why?
|
| Muscle Strength | 2 | 2018 | 32 | 0.150 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 331 | 0.140 |
Why?
|
| Nose | 1 | 2018 | 95 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 57 | 0.140 |
Why?
|
| Pain Perception | 1 | 2018 | 19 | 0.140 |
Why?
|
| Injections, Subcutaneous | 1 | 2018 | 128 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 280 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 147 | 0.130 |
Why?
|
| Health Services Misuse | 1 | 2016 | 21 | 0.130 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2016 | 14 | 0.130 |
Why?
|
| Pain Measurement | 1 | 2018 | 360 | 0.130 |
Why?
|
| Skin Ulcer | 1 | 2016 | 25 | 0.130 |
Why?
|
| Thoracic Diseases | 1 | 2016 | 27 | 0.120 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2019 | 51 | 0.120 |
Why?
|
| Logistic Models | 2 | 2021 | 1239 | 0.120 |
Why?
|
| Emergencies | 1 | 2016 | 123 | 0.120 |
Why?
|
| Equipment Design | 1 | 2016 | 420 | 0.120 |
Why?
|
| Self-Injurious Behavior | 1 | 2017 | 114 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 106 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1938 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 976 | 0.110 |
Why?
|
| Quality of Life | 1 | 2023 | 1745 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 1271 | 0.110 |
Why?
|
| United States | 5 | 2023 | 7371 | 0.100 |
Why?
|
| Obesity | 1 | 2020 | 1006 | 0.100 |
Why?
|
| Evidence-Based Nursing | 1 | 2013 | 5 | 0.100 |
Why?
|
| Microcomputers | 1 | 2013 | 26 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 253 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2021 | 9695 | 0.100 |
Why?
|
| Wireless Technology | 1 | 2012 | 21 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2014 | 373 | 0.090 |
Why?
|
| Time Factors | 2 | 2020 | 5429 | 0.090 |
Why?
|
| Curriculum | 1 | 2016 | 584 | 0.090 |
Why?
|
| Sleep, REM | 1 | 2011 | 51 | 0.090 |
Why?
|
| Exercise | 1 | 2014 | 337 | 0.090 |
Why?
|
| Patient Care | 1 | 2012 | 103 | 0.090 |
Why?
|
| Hospitalization | 1 | 2016 | 926 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2013 | 405 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2014 | 855 | 0.080 |
Why?
|
| Adolescent | 1 | 2023 | 9494 | 0.080 |
Why?
|
| Cannula | 2 | 2021 | 56 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2011 | 236 | 0.080 |
Why?
|
| Insulin | 1 | 2014 | 1165 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2011 | 215 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2012 | 474 | 0.070 |
Why?
|
| Serratia marcescens | 1 | 2025 | 12 | 0.060 |
Why?
|
| Lung | 2 | 2022 | 1338 | 0.060 |
Why?
|
| Cecum | 1 | 2025 | 76 | 0.060 |
Why?
|
| Tryptophan | 1 | 2025 | 103 | 0.060 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2025 | 72 | 0.050 |
Why?
|
| Sex Factors | 2 | 2020 | 1094 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2025 | 190 | 0.050 |
Why?
|
| Validation Studies as Topic | 1 | 2021 | 20 | 0.050 |
Why?
|
| Macrophages | 1 | 2025 | 601 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 3123 | 0.040 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2020 | 18 | 0.040 |
Why?
|
| Phrenic Nerve | 1 | 2020 | 43 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2020 | 20 | 0.040 |
Why?
|
| beta-Lactam Resistance | 1 | 2020 | 12 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 36 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2020 | 19 | 0.040 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 36 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 64 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 62 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2020 | 49 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2020 | 116 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 130 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2020 | 43 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2098 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 105 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 163 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2020 | 199 | 0.040 |
Why?
|
| High-Frequency Ventilation | 1 | 2019 | 10 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 786 | 0.040 |
Why?
|
| Pain Management | 1 | 2020 | 154 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 273 | 0.040 |
Why?
|
| Occupational Therapy | 1 | 2018 | 17 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 378 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 694 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 886 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 351 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2022 | 425 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 610 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 401 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2450 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 3376 | 0.030 |
Why?
|
| Machine Learning | 1 | 2020 | 303 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 205 | 0.030 |
Why?
|
| Chicago | 1 | 2021 | 1464 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 557 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 705 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 986 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1903 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2008 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1899 | 0.030 |
Why?
|
| Terminal Care | 1 | 2016 | 138 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1920 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2793 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1847 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3871 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 12135 | 0.020 |
Why?
|
| Polysomnography | 1 | 2011 | 152 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5706 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1772 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 28050 | 0.010 |
Why?
|